Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

619 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical efficacy and tolerability of olmesartan.
Brunner HR. Brunner HR. Clin Ther. 2004;26 Suppl A:A28-32. doi: 10.1016/s0149-2918(04)90143-9. Clin Ther. 2004. PMID: 15291377 Review.
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
Zanchi A, Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Zanchi A, et al. Among authors: brunner hr. J Clin Endocrinol Metab. 2004 Mar;89(3):1140-5. doi: 10.1210/jc.2003-031526. J Clin Endocrinol Metab. 2004. PMID: 15001599 Clinical Trial.
Volume expansion enhances plasma endothelin-1.
Abdel-Sayed S, Brunner HR, Nussberger J. Abdel-Sayed S, et al. Among authors: brunner hr. Am J Hypertens. 2003 Dec;16(12):1057-61. doi: 10.1016/s0895-7061(03)01031-8. Am J Hypertens. 2003. PMID: 14643582
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.
Michel MC, Brunner HR, Foster C, Huo Y. Michel MC, et al. Among authors: brunner hr. Pharmacol Ther. 2016 Aug;164:1-81. doi: 10.1016/j.pharmthera.2016.03.019. Epub 2016 Apr 27. Pharmacol Ther. 2016. PMID: 27130806 Free article. Review.
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes.
Wang Q, Hummler E, Nussberger J, Clément S, Gabbiani G, Brunner HR, Burnier M. Wang Q, et al. Among authors: brunner hr. J Am Soc Nephrol. 2002 Jun;13(6):1509-16. doi: 10.1097/01.asn.0000017902.77985.84. J Am Soc Nephrol. 2002. PMID: 12039980
Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor.
Cavadas C, Grand D, Mosimann F, Cotrim MD, Fontes Ribeiro CA, Brunner HR, Grouzmann E. Cavadas C, et al. Among authors: brunner hr. Regul Pept. 2003 Mar 28;111(1-3):61-5. doi: 10.1016/s0167-0115(02)00253-7. Regul Pept. 2003. PMID: 12609750
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Wuerzner G, Chioléro A, Maillard M, Nussberger J, Brunner HR, Burnier M. Wuerzner G, et al. Among authors: brunner hr. Kidney Int. 2004 Jan;65(1):238-44. doi: 10.1111/j.1523-1755.2004.00376.x. Kidney Int. 2004. PMID: 14675055 Clinical Trial.
Clinical efficacy of olmesartan medoxomil.
Brunner HR, Laeis P. Brunner HR, et al. J Hypertens Suppl. 2003 May;21(2):S43-6. doi: 10.1097/00004872-200305002-00008. J Hypertens Suppl. 2003. PMID: 12929907 Review.
Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Regamey F, Maillard M, Nussberger J, Brunner HR, Burnier M. Regamey F, et al. Among authors: brunner hr. Hypertension. 2002 Sep;40(3):266-72. doi: 10.1161/01.hyp.0000030178.90322.11. Hypertension. 2002. PMID: 12215465 Clinical Trial.
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview.
Brunner HR. Brunner HR. J Hum Hypertens. 2002 May;16 Suppl 2:S13-6. doi: 10.1038/sj.jhh.1001391. J Hum Hypertens. 2002. PMID: 11967728 Review.
619 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback